Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial

Drug-eluting stents (DES) are the recommended stents for primary percutaneous coronary intervention (PCI). This study aimed to determine why interventional cardiologists used non-DES and how it influenced patient prognoses. The efficacy and safety outcomes of the different stents were also compared...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ota Hlinomaz, Zuzana Motovska, Jiri Knot, Roman Miklik, Mahmoud Sabbah, Milan Hromadka, Ivo Varvarovsky, Jaroslav Dusek, Michal Svoboda, Frantisek Tousek, Bohumil Majtan, Stanislav Simek, Marian Branny, Jiří Jarkovský
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	acute myocardial infarction primary angioplasty drug-eluting stent bare-metal stent bioresorbable scaffolds ticagrelor Medicine R
Acceso en línea:	https://doaj.org/article/4e7652a35f734b819b5d5aa732a9c607
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial

Ejemplares similares